Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 326-332 , February 2007

NADPH oxidase inhibition prevents cocaine-induced up-regulation of xanthine oxidoreductase and cardiac dysfunction

Received 10 July 2006 ,Revised 10 November 2006 ,Accepted 20 November 2006.

References 

  1. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N. Engl. J. Med. 2001;345:351–358
  2. Devi BG, Chan AW. Effect of cocaine on cardiac biochemical functions. J. Cardiovasc. Pharmacol. 1999;33:1–6
  3. Fineschi V, Baroldi G, Centini F, Cerretani D, Fiaschi AI, Micheli L, et al. Markers of cardiac oxidative stress and altered morphology after intraperitoneal cocaine injection in a rat model. Int. J. Leg. Med. 2001;114:323–330
  4. Moritz F, Monteil C, Isabelle M, Bauer F, Renet S, Mulder P, et al. Role of reactive oxygen species in cocaine-induced cardiac dysfunction. Cardiovasc. Res. 2003;59:834–843
  5. Hargrave BY, Tiangco DA, Lattanzio FA, Beebe SJ. Cocaine, not morphine, causes the generation of reactive oxygen species and activation of NF-kappaB in transiently cotransfected heart cells. Cardiovasc. Toxicol. 2003;3:141–151
  6. Behonick GS, Novak MJ, Nealley EW, Baskin SI. Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes). J. Appl. Toxicol. 2001;21(Suppl. 1):S15–S22
  7. Amin JK, Xiao L, Pimental DR, Pagano PJ, Singh K, Sawyer DB, et al. Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes. J. Mol. Cell. Cardiol. 2001;33:131–139
  8. Bleeke T, Zhang H, Madamanchi N, Patterson C, Faber JE. Catecholamine-induced vascular wall growth is dependent on generation of reactive oxygen species. Circ. Res. 2004;94:37–45
  9. Xiao L, Pimentel DR, Wang J, Singh K, Colucci WS, Sawyer DB. Role of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes. Am. J. Physiol.: Cell Physiol. 2002;282:C926–C934
  10. Brandes RP, Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc. Res. 2005;65:16–27
  11. Isabelle M, Monteil C, Moritz F, Dautreaux B, Henry JP, Richard V, et al. Role of alpha1-adrenoreceptors in cocaine-induced NADPH oxidase expression and cardiac dysfunction. Cardiovasc. Res. 2005;67:699–704
  12. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J. Clin. Invest. 2003;111:1201–1209
  13. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol.: Heart Circ. Physiol. 2003;285:H2290–H2297
  14. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radical Biol. Med. 2002;33:774–797
  15. Ray R, Shah AM. NADPH oxidase and endothelial cell function. Clin. Sci. (Lond.). 2005;109:217–226
  16. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 2000;86:494–501
  17. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol. Sci. 2003;24:471–478
  18. Duncan JG, Ravi R, Stull LB, Murphy AM. Chronic xanthine oxidase inhibition prevents myofibrillar protein oxidation and preserves cardiac function in a transgenic mouse model of cardiomyopathy. Am. J. Physiol.: Heart Circ. Physiol. 2005;289:H1512–H1518
  19. Kinugawa S, Huang H, Wang Z, Kaminski PM, Wolin MS, Hintze TH. A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ. Res. 2005;96:355–362
  20. Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, et al. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J. Mol. Cell. Cardiol. 2005;39:531–536
  21. Mellin V, Isabelle M, Oudot A, Vergely-Vandriesse C, Monteil C, Di Meglio B, et al. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure. Eur. Heart J. 2005;26:1544–1550
  22. Landmesser U, Spiekermann S, Dikalov S, Tatge H, Wilke R, Kohler C, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation. 2002;106:3073–3078
  23. Li Y, Zhu H, Kuppusamy P, Roubaud V, Zweier JL, Trush MA. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems. J. Biol. Chem. 1998;273:2015–2023
  24. Beckman JS, Parks DA, Pearson JD, Marshall PA, Freeman BA. A sensitive fluorometric assay for measuring xanthine dehydrogenase and oxidase in tissues. Free Radical Biol. Med. 1989;6:607–615
  25. Crapo JD, McCord JM, Fridovich I. Preparation and assay of superoxide dismutases. Methods Enzymol. 1978;53:382–393
  26. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126
  27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987;162:156–159
  28. Morrison TB, Weis JJ, Wittwer CT. Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. BioTechniques. 1998; 24: 954–8, 960, 962.
  29. Cotter MA, Cameron NE. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats. Life Sci. 2003;73:1813–1824
  30. Zimmerman MC, Dunlay RP, Lazartigues E, Zhang Y, Sharma RV, Engelhardt JF, et al. Requirement for Rac1-dependent NADPH oxidase in the cardiovascular and dipsogenic actions of angiotensin II in the brain. Circ. Res. 2004;95:532–539
  31. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, et al. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radical Biol. Med. 2004;37:115–123
  32. Park YM, Park MY, Suh YL, Park JB. NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats. Biochem. Biophys. Res. Commun. 2004;313:812–817
  33. Rasmussen JT, Rasmussen MS, Petersen TE. Cysteines involved in the interconversion between dehydrogenase and oxidase forms of bovine xanthine oxidoreductase. J. Dairy Sci. 2000;83:499–506
  34. Sakuma S, Fujimoto Y, Sakamoto Y, Uchiyama T, Yoshioka K, Nishida H, et al. Peroxynitrite induces the conversion of xanthine dehydrogenase to oxidase in rabbit liver. Biochem. Biophys. Res. Commun. 1997;230:476–479
  35. Kono Y, Fridovich I. Superoxide radical inhibits catalase. J. Biol. Chem. 1982;257:5751–5754

PII: S0022-2828(06)01033-9

doi: 10.1016/j.yjmcc.2006.11.011

Journal of Molecular and Cellular Cardiology
Volume 42, Issue 2 , Pages 326-332 , February 2007

Article Tools

* Image Usage & Resolution